Blood-Brain Barrier In Vitro Models and Their Application in Toxicology: The Report and Recommendations of ECVAM Workshop 491,2
暂无分享,去创建一个
Anna Forsby | Sandra Coecke | Anna Price | Hanna Tähti | John Greenwood | Bas J. Blaauboer | Hans-Joachim Galla | J. Greenwood | R. Cecchelli | H. Galla | B. Blaauboer | H. Tähti | S. Coecke | A. Forsby | P. Prieto | Cecilia Clemedson | Pilar Prieto | Per Garberg | Romeo Cecchelli | A. D. De Boer | A. Price | Monica Boveri | C. Clemedson | Albertus Gerrit de Boer | M. Boveri | P. Garberg
[1] J. Ghersi-Egea,et al. Demonstration of a Coupled Metabolism–Efflux Process at the Choroid Plexus as a Mechanism of Brain Protection Toward Xenobiotics , 1999, The Journal of Neuroscience.
[2] A. Strosberg,et al. Regulation of gamma‐glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells , 1994, Journal of cellular physiology.
[3] N. Tandon,et al. Plasmodium falciparum: involvement of additional receptors in the cytoadherence of infected erythrocytes to microvascular endothelial cells. , 1996, Experimental parasitology.
[4] P. Friedl,et al. Establishment of the permanent microvascular endothelial cell line PBMEC/C1-2 from porcine brains. , 1996, Experimental cell research.
[5] L. Fenart,et al. In vitro model for evaluating drug transport across the blood-brain barrier. , 1999, Advanced drug delivery reviews.
[6] J. DeJongh,et al. Role of kinetics in acute lethality of nonreactive volatile organic compounds (VOCs). , 1998, Toxicological sciences : an official journal of the Society of Toxicology.
[7] T. Terasaki,et al. Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. , 2001, Biological & pharmaceutical bulletin.
[8] J. Ghersi-Egea,et al. Choroid Plexus Transporters for Drugs and Other Xenobiotics , 2002, Journal of drug targeting.
[9] J. Tonn,et al. Characteristic gene expression profile of primary human cerebral endothelial cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] H. Galla,et al. Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. , 1998, Biochemical and biophysical research communications.
[11] P Delorme,et al. An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro , 1990, Journal of neurochemistry.
[12] C. Catania,et al. Neurons and ECM regulate occludin localization in brain endothelial cells , 2000, Neuroreport.
[13] M. Schroeter,et al. *NO and oxyradical metabolism in new cell lines of rat brain capillary endothelial cells forming the blood-brain barrier. , 2001, Microvascular research.
[14] K. Krishnan,et al. A tissue composition-based algorithm for predicting tissue:air partition coefficients of organic chemicals. , 1996, Toxicology and applied pharmacology.
[15] B. McEwen,et al. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. , 2001, Annual review of pharmacology and toxicology.
[16] M. Dehouck,et al. Drug transport to the brain: comparison between in vitro and in vivo models of the blood-brain barrier , 1995 .
[17] L. Rubin,et al. The cell biology of the blood-brain barrier. , 1999, Annual review of neuroscience.
[18] M E Andersen,et al. Physiological modelling of organic compounds. , 1991, The Annals of occupational hygiene.
[19] M. Dehouck,et al. Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. , 1996, The American journal of physiology.
[20] Donald W. Miller,et al. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. , 2001, The Journal of pharmacology and experimental therapeutics.
[21] D. Scherman,et al. Induction of blood-brain barrier differentiation in a rat brain-derived endothelial cell line. , 1995, Experimental cell research.
[22] N. Yamamoto,et al. Induction of blood–brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors , 1999, Neuroscience Research.
[23] M. Dehouck,et al. Endothelin-1 as a Mediator of Endothelial Cell–Pericyte Interactions in Bovine Brain Capillaries , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] D. Breimer,et al. Glucocorticoid and type 1 interferon interactions at the blood–brain barrier: relevance for drug therapies for multiple sclerosis , 2001, Neuroreport.
[25] Worth Andrew,et al. Alternative (Non-Animal) Methods for Chemicals Testing: Current Status and Future Prospects (A Report Prepared by ECVAM and the ECVAM WG on Chemicals) , 2002 .
[26] C. Meulenberg,et al. Empirical relations predicting human and rat tissue:air partition coefficients of volatile organic compounds. , 2000, Toxicology and applied pharmacology.
[27] H. Galla,et al. Tyrosine phosphatase inhibition induces loss of blood–brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways , 2004, Brain Research.
[28] H. Kusuhara,et al. Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1). , 2001, Drug discovery today.
[29] J B Houston,et al. An Integrated Approach to the Prediction of Systemic Toxicity using Computer-based Biokinetic Models and Biological In vitro Test Methods: Overview of a Prevalidation Study Based on the ECITTS Project. , 1999, Toxicology in vitro : an international journal published in association with BIBRA.
[30] N. Shaik,et al. Drug efflux transporters in the CNS. , 2003, Advanced drug delivery reviews.
[31] J. DeJongh,et al. A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans , 1997, Archives of Toxicology.
[32] J. Prins. Directive 2003/98/EC of the European Parliament and of the Council , 2006 .
[33] H. Tähti,et al. Development of an in vitro blood-brain barrier model-cytotoxicity of mercury and aluminum. , 2004, Toxicology and applied pharmacology.
[34] L. Fenart,et al. Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier* , 1999, The Journal of Biological Chemistry.
[35] A. Gaillard,et al. In Vitro Models of the Blood-Brain Barrier: When to Use Which? , 2002 .
[36] M. Dehouck,et al. Bovine Brain Endothelial Cells Express Tight Junctions and Monoamine Oxidase Activity in Long‐Term Culture , 1989, Journal of neurochemistry.
[37] C. Engelbertz,et al. Porcine choroid plexus epithelial cells in culture: Regulation of barrier properties and transport processes , 2001, Microscopy research and technique.
[38] H. Bauer,et al. Neural Induction of the Blood–Brain Barrier: Still an Enigma , 2000, Cellular and Molecular Neurobiology.
[39] G. Weinmaster,et al. Notch4 and Jagged-1 induce microvessel differentiation of rat brain endothelial cells. , 2000, Microvascular research.
[40] D. Begley,et al. Lipids in blood-brain barrier models in vitro II: Influence of glial cells on lipid classes and lipid fatty acids , 2002, In Vitro Cellular & Developmental Biology - Animal.
[41] I. Sherman,et al. Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells. , 1996, International journal for parasitology.
[42] H. Drexler,et al. Bladder carcinoma cell line ECV304 is not a model system for endothelial cells , 2002, In Vitro Cellular & Developmental Biology - Animal.
[43] E. Walum,et al. Determination of Critical Cellular Neurotoxic Concentrations in Human Neuroblastoma (SH-SY5Y) Cell Cultures , 1995 .
[44] E. Hogan,et al. Receptor‐Linked Hydrolysis of Phosphoinositides and Production of Prostacyclin in Cerebral Endothelial Cells , 1992, Journal of neurochemistry.
[45] L. Devine,et al. SV40 large T immortalised cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics , 1996, Journal of Neuroimmunology.
[46] H. Takanaga,et al. Blood—Brain Barrier Is Involved in the Efflux Transport of a Neuroactive Steroid, Dehydroepiandrosterone Sulfate, via Organic Anion Transporting Polypeptide 2 , 2000, Journal of neurochemistry.
[47] D. Breimer,et al. Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro. , 2003, Microvascular research.
[48] R. Bendayan,et al. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. , 2001, Pharmacological reviews.
[49] J. Brillault,et al. Prediction of Drug Transport Through the Blood-Brain Barrier in Vivo: A Comparison Between Two in Vitro Cell Models , 2002, Pharmaceutical Research.
[50] R. Monette,et al. Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood–brain barrier , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[51] C. Engelbertz,et al. Expression and adhesive properties of basement membrane proteins in cerebral capillary endothelial cell cultures , 2002, Cell and Tissue Research.
[52] Meihua Rose Feng,et al. Assessment of blood-brain barrier penetration: in silico, in vitro and in vivo. , 2002, Current drug metabolism.
[53] C. Lohmann,et al. Predicting Blood-Brain Barrier Permeability of Drugs: Evaluation of Different In Vitro Assays , 2002, Journal of drug targeting.
[54] H. Galla,et al. Recent Advances in the Development of Cell Culture Models for the Blood-Brain- and Blood-CSF-Barrier , 2001 .
[55] J. DeJongh,et al. Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulations. , 1999, Toxicology and applied pharmacology.
[56] B. Veronesi. Characterization of the MDCK cell line for screening neurotoxicants. , 1996, Neurotoxicology.
[57] S. Kajiji,et al. P-glycoprotein efflux at the blood-brain barrier mediates differences in brain disposition and pharmacodynamics between two structurally related neurokinin-1 receptor antagonists. , 2001, The Journal of pharmacology and experimental therapeutics.
[58] D. Janigro,et al. Understanding the Physiology of the Blood-Brain Barrier: In Vitro Models. , 1998, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[59] D. Mooradian,et al. Production of a transforming growth factor-beta-like growth factor by RSV-transformed rat cerebral microvascular endothelial cells. , 1991, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[60] D D Breimer,et al. The blood-brain barrier in neuroinflammatory diseases. , 1997, Pharmacological reviews.
[61] L. Fenart,et al. Inhibition of P-Glycoprotein: Rapid Assessment of Its Implication in Blood-Brain Barrier Integrity and Drug Transport to the Brain by an In Vitro Model of the Blood-Brain Barrier , 1998, Pharmaceutical Research.
[62] H. Galla,et al. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood–brain barrier , 2003, Brain Research.
[63] I. Tamai,et al. Functional Clarification of MCT1-Mediated Transport of Monocarboxylic Acids at the Blood-Brain Barrier Using In Vitro Cultured Cells and In Vivo BUI Studies , 2004, Pharmaceutical Research.
[64] R. Shivers,et al. Immortalized mouse brain endothelial cells are ultrastructurally similar to endothelial cells and respond to astrocyte-conditioned medium , 1998, In Vitro Cellular & Developmental Biology - Animal.
[65] T. Tsuruo,et al. [Functional involvement of P-glycoprotein in blood-brain barrier]. , 1992, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[66] N. Prasadarao,et al. Bovine brain microvascular endothelial cells transfected with SV40-large T antigen: Development of an immortalized cell line to study pathophysiology of CNS disease , 1997, In Vitro Cellular & Developmental Biology - Animal.
[67] Thomas J. Raub,et al. In vitro models of the blood-brain barrier. , 1998, Alternatives to laboratory animals : ATLA.
[68] B. Blaauboer. Biokinetic and Toxicodynamic Modelling and its Role in Toxicological Research and Risk Assessment , 2003, Alternatives to laboratory animals : ATLA.
[69] C. Ringbom,et al. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[70] Tarja Toimela,et al. Refining In Vitro Neurotoxicity Testing — The Development of Blood–Brain Barrier Models , 2003, Alternatives to laboratory animals : ATLA.
[71] H. Drexler,et al. ECV304 (endothelial) is really T24 (bladder carcinoma): Cell line cross-contamination at source , 1999, In Vitro Cellular & Developmental Biology - Animal.
[72] H. Galla,et al. Serum-derived factors weaken the barrier properties of cultured porcine brain capillary endothelial cells in vitro , 2003, Brain Research.